Piramal Pharma Solutions’ UK facility bags updated MHRA GMP certification
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Consolidated revenue from operations stood at Rs. 111.05 crore
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
Subscribe To Our Newsletter & Stay Updated